| Entero Therapeutics, Inc. (ENTO) | |||||||||||||||||||||||||||||||||||||||||||||||||
| Q4-CY2025 | Q3-CY2025 | Q2-CY2025 | Q1-CY2025 | Q4-CY2024 | Q3-CY2024 | Q2-CY2024 | Q1-CY2024 | Q4-CY2023 | Q3-CY2023 | Q2-CY2023 | Q1-CY2023 | Q4-CY2022 | Q3-CY2022 | Q2-CY2022 | Q1-CY2022 | Q4-CY2021 | Q3-CY2021 | Q2-CY2021 | Q1-CY2021 | Q4-CY2020 | Q3-CY2020 | Q2-CY2020 | Q1-CY2020 | Q4-CY2019 | Q3-CY2019 | Q2-CY2019 | Q1-CY2019 | Q4-CY2018 | Q3-CY2018 | Q2-CY2018 | Q1-CY2018 | Q4-CY2017 | Q3-CY2017 | Q2-CY2017 | Q1-CY2017 | Q4-CY2016 | Q3-CY2016 | Q2-CY2016 | Q1-CY2016 | Q4-CY2015 | Q3-CY2015 | Q2-CY2015 | Q1-CY2015 | Q4-CY2014 | Q3-CY2014 | Q2-CY2014 | Q1-CY2014 | Q4-CY2013 | |
| Balance Sheet Date | 2025-Sep-30 | 2025-Jun-30 | 2025-Mar-31 | 2024-Dec-31 | 2024-Sep-30 | 2024-Jun-30 | 2024-Mar-31 | 2023-Dec-31 | 2023-Sep-30 | 2023-Jun-30 | 2023-Mar-31 | 2022-Dec-31 | 2022-Sep-30 | 2022-Jun-30 | 2022-Mar-31 | 2021-Dec-31 | 2021-Sep-30 | 2021-Jun-30 | 2021-Mar-31 | 2020-Dec-31 | 2020-Sep-30 | 2020-Jun-30 | 2020-Mar-31 | 2019-Dec-31 | 2019-Sep-30 | 2019-Jun-30 | 2019-Mar-31 | 2018-Dec-31 | 2018-Sep-30 | 2018-Jun-30 | 2018-Mar-31 | 2017-Dec-31 | 2017-Sep-30 | 2017-Jun-30 | 2017-Mar-31 | 2016-Dec-31 | 2016-Sep-30 | ||||||||||||
| Fiscal Period | Q3-FY2025 | Q2-FY2025 | Q1-FY2025 | Q4-FY2024 | Q3-FY2024 | Q2-FY2024 | Q1-FY2024 | Q4-FY2023 | Q3-FY2023 | Q2-FY2023 | Q1-FY2023 | Q4-FY2022 | Q3-FY2022 | Q2-FY2022 | Q1-FY2022 | Q4-FY2021 | Q3-FY2021 | Q2-FY2021 | Q1-FY2021 | Q4-FY2020 | Q3-FY2020 | Q2-FY2020 | Q1-FY2020 | Q4-FY2019 | Q3-FY2019 | Q2-FY2019 | Q1-FY2019 | Q4-FY2018 | Q3-FY2018 | Q2-FY2018 | Q1-FY2018 | Q4-FY2017 | Q3-FY2017 | Q2-FY2017 | Q1-FY2017 | Q4-FY2016 | Q3-FY2016 | ||||||||||||
| Price to Sales | |||||||||||||||||||||||||||||||||||||||||||||||||
| Price to Book | .30x | .86x | - | - | - | .10x | .35x | ||||||||||||||||||||||||||||||||||||||||||
| Price to Earnings | - | - | - | - | - | - | - | ||||||||||||||||||||||||||||||||||||||||||
| Price to Unlevered FCF | - | - | - | - | - | - | - | ||||||||||||||||||||||||||||||||||||||||||
| Debt to Asset Ratio | .34x | .35x | .34x | .32x | .18x | .18x | .15x | .48x | .45x | .80x | .51x | .50x | 1.49x | 4.61x | 2.05x | 1.66x | 1.56x | .49x | .20x | 1.20x | .16x | 1.12x | .63x | .48x | .66x | .69x | .70x | .40x | .36x | .35x | .79x | .70x | .59x | .47x | .73x | .52x | 3.21x | 1.54x | |||||||||||
| Current Ratio | 2.62x | 2.81x | 2.90x | 3.03x | 5.34x | 5.49x | 1.21x | 1.58x | 1.60x | .72x | 1.34x | 1.37x | .38x | .10x | .46x | .77x | .39x | 1.33x | 3.68x | .51x | 4.39x | .21x | .56x | .80x | .64x | .58x | .49x | 1.60x | 3.88x | 3.31x | .64x | .79x | 1.17x | 1.97x | .66x | 1.27x | .09x | .23x | |||||||||||